|
End-of-day quote
Shanghai S.E.
20/08/2026
|
5-day change | 1st Jan Change | ||
| 12.92 CNY | +2.46% |
|
+2.54% | +10.43% |
| 05-26 | Guizhou Sanli Pharmaceutical to Raise Up to 700 Million Yuan in Private Placement | MT |
| 05-25 | Guizhou Sanli pharmaceutical to raise funds via private placement | RE |
| Market Cap | 5.23B 779M 665M 622M 570M 1.07B 74.51B 1.09B 7.37B 2.87B 37.37B 2.92B 2.86B 124B | P/E 2024 |
19.4x | P/E 2025 | 106x |
|---|---|---|---|---|---|
| Enterprise Value | 5.58B 831M 710M 663M 608M 1.14B 79.48B 1.17B 7.86B 3.06B 39.86B 3.12B 3.05B 132B | EV / Sales 2024 |
2.48x | EV / Sales 2025 | 2.99x |
| Free-Float |
40.62% | Yield 2024 |
2.62% | Yield 2025 | 0.51% |
| 1 day | +2.46% | ||
| 1 week | +2.54% | ||
| Current month | +25.68% | ||
| 1 month | +17.99% | ||
| 3 months | +3.28% | ||
| 6 months | +7.85% | ||
| Current year | +10.43% |
| 1 week | 12.45 |  | 13.71 |
| 1 month | 9.51 | | 13.71 |
| Current year | 9.51 | | 17.46 |
| 1 year | 9.51 | | 17.46 |
| 3 years | 9.51 | | 20.34 |
| 5 years | 9.51 | | 21.28 |
| 10 years | 8.82 | | 44.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Qian Fan Zhang
CEO | Chief Executive Officer | 41 | 27/05/2024 |
Hai Zhang
CEO | Chief Executive Officer | 41 | 01/09/2011 |
Ke Guo
DFI | Director of Finance/CFO | 39 | 01/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Shi Gui Chen
BRD | Director/Board Member | 63 | 12/12/2022 |
Wei Sheng Feng
BRD | Director/Board Member | 66 | 10/10/2024 |
Hai Zhang
CHM | Chairman | 41 | 01/03/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/9/24 | Sell | Chief Executive Officer | 21,000,000 | 5.1428% | ||
| 2/8/24 | Buy | Director | 13,000 | 0.0032% | ||
| 5/8/23 | Sell | 25,000 | 0.0061% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.46% | +2.54% | -1.45% | -16.38% | 758M | |
| -2.81% | +1.98% | +76.96% | +127.73% | 1,141B | |
| -2.21% | +2.50% | +50.38% | +55.01% | 659B | |
| -1.56% | +5.25% | +26.98% | +74.39% | 470B | |
| +1.20% | +1.72% | +42.89% | +45.78% | 366B | |
| -0.61% | +1.72% | +25.21% | +41.34% | 302B | |
| +0.32% | +3.30% | +2.60% | +13.42% | 254B | |
| -1.95% | +4.22% | +46.75% | +65.66% | 239B | |
| -1.10% | -1.12% | -14.91% | -52.66% | 207B | |
| -2.82% | +5.57% | +21.58% | +89.04% | 183B | |
| Average | -0.22% | +3.24% | +27.70% | +44.33% | 382.17B | |
| Weighted average by Cap. | -0.09% | +4.31% | +44.41% | +70.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 319M 273M 255M 234M 439M 30.55B 449M 3.02B 1.18B 15.32B 1.2B 1.17B 50.78B | 1.7B 254M 217M 203M 186M 349M 24.26B 356M 2.4B 935M 12.17B 952M 931M 40.32B |
| Net income | 274M 40.8M 34.87M 32.59M 29.87M 56.13M 3.9B 57.36M 386M 150M 1.96B 153M 150M 6.49B | 46.25M 6.89M 5.89M 5.5M 5.04M 9.48M 659M 9.68M 65.17M 25.39M 331M 25.86M 25.3M 1.1B |
| Net Debt | 108M 16.03M 13.7M 12.8M 11.74M 22.06M 1.53B 22.54M 152M 59.1M 769M 60.19M 58.88M 2.55B | 349M 51.92M 44.37M 41.47M 38.01M 71.43M 4.97B 73M 491M 191M 2.49B 195M 191M 8.26B |
Employees
1,887
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | CN¥12.92 | +2.46% | 10,481,200 |
| 19/08/26 | CN¥12.61 | -0.86% | 14,273,676 |
| 18/08/26 | CN¥12.72 | -4.43% | 18,524,153 |
| 17/08/26 | CN¥13.31 | -1.63% | 23,809,024 |
| 14/08/26 | CN¥13.53 | +4.64% | 29,785,385 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 603439 Stock
Select your edition
All financial news and data tailored to specific country editions
